Highlights 1) Map3k2 protects mice from DSS-induced colitis by promoting intestinal stem cell regeneration.
Introduction
Stem cell proliferation and differentiation are critical for rapid repair of intestinal injury and maintenance of host health (Nanki et al., 2018) . Intestinal stem cells (ISC) are thought to rely on specific signals and growth factors produced by the local niche that support their repair functions and self-renewal in the crypts (Aoki et al., 2016; Degirmenci et al., 2018; Greicius et al., 2018; Kabiri et al., 2014; Sato et al., 2011; Shoshkes-Carmel et al., 2018) . In particular, diverse populations of intestinal mesenchymal stromal cells (IMSC) appear to play key roles in ISC niche maintenance via sensing of factors including FGF, TGF-β, Hedgehog, and PDGF (Koch, 2017; Roulis and Flavell, 2016; Valenta et al., 2016) , but the specific IMSC subsets and molecular mediators involved are unknown.
Several studies have now suggested that CD90 + IMSC may be crucial regulators of gut homeostasis (Huynh et al., 2016; Karpus et al., 2019; Kinchen et al., 2018; Powell et al., 2011; Roulis et al., 2014) . However, recent efforts to understand the heterogeneity and function of ISMC using single-cell RNA sequencing (scRNA-seq) and lineage tracing techniques have revealed the existence of multiple functionally distinct subsets (Kinchen et al., 2018; Nanki et al., 2018) , many of which produce soluble factors and cytokines likely capable of modulating gut homeostasis and epithelial integrity (Han et al., 2018; Kinchen et al., 2018; Shoshkes-Carmel et al., 2018; Thomson et al., 2018) . In particular, IMSC expressing SOX6, CD142 and Wnt pathway genes appear to localize to intestinal crypts and can support epithelial stem cell function (Kinchen et al., 2018) , while a population of GLI1-expressing IMSC localized in the pericrypt area has also been shown to mediate colonic stem cell renewal in a murine model (Degirmenci et al., 2018) . Similarly two separate populations of fibroblast-like stromal cells (expressing Ackr4 + /CD34 + or Foxl1 + /F3 + ) in the pericrypt region have been reported to drive stem cell proliferation and gut organoid growth in vitro, likely via production of ligands/agonists of the Wnt and BMP pathways (Aoki et al., 2016; Shoshkes-Carmel et al., 2018; Stzepourginski et al., 2017; Thomson et al., 2018) . However, it is currently unclear to what extent these different IMSC populations exert redundant functions or play different roles in gut tissue health and disease states.
The Map3k2 gene encodes a serine/threonine protein kinase belonging to the MAP3K superfamily (Cheng et al., 2000; Guo et al., 2002; Su et al., 2001; Sun et al., 2001; Zhang et al., 2006) . Map3k2 signaling is triggered by a range of soluble factors including FGF, PDGF, TGF-β, TNF-α and IL-1β, leading to activation of downstream effectors ERK1/2, JNK, p38 and ERK5 via their respective MAPK kinases (Chang et al., 2011; Cheng et al., 2005; Greenblatt et al., 2016; Sun et al., 2001; Tsioumpekou et al., 2016; Zhang et al., 2006) . Map3k2 is constitutively expressed in multiple mouse organs including various cell types that are resident in the gut (Guo et al., 2002; Han et al., 2018) .
In this report, we used scRNA-seq in combination with flow-cytometry and qRT-PCR to identify a novel population of CD81 + sub-crypt intestinal stromal cells that depend on a specific MAP3K2 signaling cascade to augment expression of Wnt agonist Rspo1. We further demonstrate that this signaling axis is critically required for rapid regeneration of damaged intestine via induction of epithelial stem cell proliferation and survival in the colon, leading to efficient host protection against DSS-induced colitis. Together, our data uncover a novel population of stromal cells that maintains an epithelial stem cell niche capable of efficient regeneration of the acutely damaged intestine.
Results

Map3k2 Protects Mice against DSS-Induced Colitis
Map3k2 is expressed in the gut epithelium, stromal and hematopoietic compartments, but germline deficiency of Map3k2 exerts minimal effect on normal mouse growth (Chang et al., 2011; Guo et al., 2002) . To investigate the role of Map3k2 in intestinal inflammation, we used an acute colitis model in which co-housed littermates of wild type (WT) and Map3k2 -/mice were administered 2% DSS in their drinking water for 7 days followed by regular drinking water for a further two days thereafter. Within 5-6 days of DSS intake, we observed that Map3k2 -/mice suffered greater loss of body weight (Figure 1A) and worse diarrhea ( Figure 1B) than did WT mice.
Endoscopic examination after DSS treatment also revealed more severe bleeding, ulceration, and colonic swelling in Map3k2 -/mice than in WT mice ( Figure 1C) . Furthermore, Map3k2 -/mice also exhibited significantly shorter colon length (Figure 1D ) as well as more severe epithelial damage and greater leukocyte infiltration than were observed in WT mice on day 9 after DSS treatment ( Figure 1E) . These data reveal that Map3k2 plays an important role in host protection against acute intestinal tissue damage.
Map3k2 is Required for Intestinal Epithelium Regeneration In Vivo
Given the more severe colonic damage induced by DSS administration in Map3k2 -/mice, we next assessed which specific cell types might be associated with the pathology observed in these animals. While baseline goblet cell number and capacity for mucin production were comparable in colon from both WT and Map3k2 -/mice, after 5 days DSS treatment goblet cell number were substantially reduced and spatial distribution was altered in colonic tissue from Map3k2 -/animals ( Figure 1F) . These features were even more pronounced by day 7-9, at which point the Map3k2 -/mice almost entirely lacked mucin producing cells in the gut epithelium (Figures 1F and 1G) .
Consistently, mRNA levels of the goblet cell-specific marker Muc2 were dramatically reduced in Map3k2-deficient colon comparing to WT colon that were subjected to the same DSS treatment ( Figure 1H) . Ki67 staining also revealed that proliferation of colonic epithelial cells in response to DSS treatment was dramatically reduced in Map3k2 -/mice compared with WT mice (Data not shown). Reg4 + Deep Crypt Secreting (DCS) cells also displayed hallmarks of increased damage in Map3k2-deficient colon (Data not shown). Together, these data demonstrated that multiple lineages of intestinal epithelial cells were severely disrupted in the colon of Map3k2 -/mice, suggesting that this kinase may be critical for stem cell-mediated epithelial regeneration following acute injury.
Map3k2 Plays a Critical Role in Maintaining Intestinal Stem Cell Frequency
Intestinal stem cell (ISC) proliferation and differentiation are crucial for regeneration of the gut epithelium (Barker et al., 2010) . Given the severity of epithelial damage observed in Map3k2 -/mice after DSS treatment, we next examined whether ISC survival and differentiation were defective in the absence of the Map3k2 enzyme. We therefore examined colonic expression levels of the archetypal ISC genes Lgr5 (Barker et al., 2007) , Ascl2 (Schuijers et al., 2015) and Hopx (Takeda et al., 2011) by qRT-PCR, which suggested a greater loss of this cell type in DSS-exposed intestinal tissue from Map3k2-deficient mice relative to WT animals (Figure 2A) . To confirm these results, we next established Lgr5-EGFP reporter mice both on WT (WT-Lgr5-EGFP) and Map3k2 -/-(Map3k2 -/--Lgr5-EGFP) backgrounds to facilitate better comparison of the number of Lgr5-EGFP + cells present both before and after DSS treatment. In the absence of DSS treatment, numbers of Lgr5-EGFP + cells were comparable between colons from WT and Map3k2 -/mice, but DSS-induced damage consistently led to a greater reduction in Lgr5-EGFP + stem cells in Map3k2 -/animals, whether assessed by flow cytometry (Figures 2B and 2C 
Map3k2 is Dispensable for ISC Proliferation and Differentiation
The above data suggested that Map3k2 might play a critical role in ISC survival, proliferation and/or differentiation into mature gut epithelial lineages including goblet cells. To investigate this possibility, we isolated intestinal crypts from WT and Map3k2 -/mice for ex vivo culture (Sato et al., 2009) . To our surprise, there was no difference in growth rates between organoids derived from WT and Map3k2 -/animals (Figures 2F-2H ). Furthermore, qRT-PCR analyses confirmed there was no difference in expression of hallmark genes of intestinal stem cells, enterocytes, goblet cells, enteroendocrine cells, Reg4 + DCS cells, or tuft cells (Figure 2I) . These data suggested that Map3k2 is not intrinsically required for ISC growth, survival and differentiation, hence the defects observed in Map3k2 -/mice in vivo are likely due to impairment of other cell types surrounding the stem cells and enterocytes.
Map3k2 Expression in Hematopoietic Cells is Not Required for Protection Against Colitis
Multiple hematopoietic and non-hematopoietic lineages are required to protect the gut against tissue damage. Since Map3k2 is ubiquitously expressed in almost all types of intestinal cells, we postulated that the severe colonic damage observed in Map3k2 -/mice could be due to functional impairment of one or many different cell types in the gut (colonic epithelial cells, stromal cells, or hematopoietic leukocytes). We therefore performed a series of bone marrow transfers, using cells from either WT or Map3k2 -/donor mice to reconstitute lethally irradiated WT or Map3k2 -/recipient animals prior to induction of DSS colitis. Severity of inflammation was comparable in WT recipient mice irrespective of whether the bone marrow grafts were derived from WT or Map3k2deficient donors, as measured by loss of body weight (Figure S1A), diarrhea severity score (Figure S1B), colon length (Figure S1C), or epithelial integrity ( Figure S1D ). We were also unable to detect any difference in Lgr5 or Gob5 expression in DSS-treated intestine from WT mice that had received grafts of either type (Figure S1E ), suggesting that expression of Map3k2 in hematopoietic cells was not required for protection against acute tissue damage. These findings therefore indicated that Map3k2 expression in non-hematopoietic epithelium or tissue stroma may be critical for tissue repair after DSS-induced injury. Indeed, transfer of WT donor bone marrow into Map3k2 -/recipient mice was unable to rescue these animals from severe colitis (Figures S1F-S1I), and lack of Map3k2 function only in non-hematopoietic cells was sufficient to replicate the loss of colonic epithelial stem cells and goblet cells conferred by global gene deletion (Figure S1J) .
Map3k2 is Essential for Wnt Signaling in the Colon
To better understand the molecular basis of Map3k2-mediated protection against DSSinduced colitis, we next isolated and sequenced total RNA from the colons of WT and Map3k2 -/mice after one day exposure to DSS or normal drinking water. In order to identify key Map3k2 target genes and associated signaling pathways, genes that were differentially expressed between the paired samples were determined using Gene Set Enrichment Analysis (GSEA). Using this approach, we detected significant up-regulation of chemokine genes in Map3k2-deficient colon after DSS exposure, consistent with the increased inflammatory infiltrate observed in these animals, whereas genes involved in MAPK signaling were down-regulated as expected (Data not shown).
However, when we assessed expression levels of genes associated with intestinal stem cell survival and maintenance, we observed that Map3k2 -/mice exhibit potent down-regulation of Wnt signaling genes ( Figure 3A) but not the Notch or EGF pathways ( Figure 3B ). Furthermore, while expression of Wnt pathway genes in untreated colon tissue was comparable between WT and Map3k2 -/animals, DSS exposure was associated with a dramatic down-regulation of key Wnt pathwayassociated genes such as Axin2, Fzd8, Nr4a3 and Rspo1 in Map3k2-deficient colon (Figures 3A   and 3C ). Furthermore, the overall levels of the ligands, receptors, and mediators of the Wnt pathway were all down regulated in Map3k2-deficient colon after DSS treatment (Figure 3D ), strongly indicating that Map3k2 critically regulates Wnt signaling in order to protect the colon against DSS-induced epithelial damage. Among the Wnt-related genes identified above, Rspo1 was the most significantly downregulated in Map3k2-deficient colon (Figures 3A and 3C) , consistent with the reports that Rspo1 plays an essential role in maintaining the ISC niche (Kim et al., 2005; Ootani et al., 2009; Sato et al., 2009; Zhao et al., 2007; Zhou et al., 2013) . Accordingly, we observed that reducing the concentrations of R-spondin1 in the in vitro culture media led to dose-dependent decreases in growth and survival of intestinal organoids (Figures S2A-S2C) , strongly suggesting that peri-crypt concentrations of R-spondin1 may be equally critical for proliferation and survival of gut epithelial 1 0 stem cells in vivo.
Recombinant R-spondin1 Rescues Map3k2 -/-Mice from DSS-Induced Severe Colitis
To determine whether Map3k2 is crucial for R-spondin1 induction and protection against DSS-induced intestinal damage, we next performed a rescue experiment using human recombinant (rec) R-spondin1. Specifically, Map3k2 -/mice were administered 2% DSS in drinking water with daily intraperitoneal injection of 5 µg recR-spondin1 or saline-only control. As shown in Figures   3E and 3F , recR-spondin1 markedly reduced colitis severity in Map3k2 -/mice as indicated by less pronounced weight loss ( Figure 3E ) and milder symptoms of diarrhea ( Figure 3F ). Expression of inflammatory cytokines such as Il6 and Tnfα was also dramatically reduced in recR-spondin1treated mice colon tissues ( Figure 3G) . We further observed a partial rescue of goblet cell numbers as assessed by AB/PAS staining (Figure 3H) , together with increased mRNA expression of Lgr5 ( Figure 3I) . Together, these data strongly suggest that the protective role of Map3k2 in DSSinduced colitis is mediated via up-regulation of Rspo1.
Map3k2 Regulates Intestinal Mesenchymal Stromal Cell Induction of R-spondin1
R-spondin1 is crucial for optimal activation of the Wnt pathway, which plays wellrecognized roles in maintaining gut integrity and repairing acute tissue damage (Binnerts et al., 2007; de Lau et al., 2014; Kim et al., 2005; Kretzschmar and Clevers, 2017; Pinto et al., 2003; Yan et al., 2017) . However, the cellular sources of Wnt agonist R-spondin1 in the damaged gut have not been clearly defined. In order to uncover the key cellular source of Map3k2-dependent Rspo1 expression in the DSS-damaged gut, we used flow cytometry to sort CD326 + CD45intestinal epithelial cells (IECs), CD45 + CD326hematopoietic cells (CD45 + ), and CD326 -CD45 -CD31 -gp38 + intestinal mesenchymal stromal cells (gp38 + stroma) from untreated and DSS-challenged mouse colon ( Figure 4A ). In addition, we used anti-CD90 antibody to sort the gp38 + stromal fraction into CD90 + IMSC and CD90 -IMSC subsets before assessing Rspo1 expression by qRT-PCR. As predicted, we were unable to detect Rspo1 expression in sorted IEC, whereas CD45 + hematopoietic cells and CD90 -IMSC expressed only low levels of Rspo1 (Figure 4B) . In contrast, CD90 + IMSC displayed marked production of Rspo1 and higher expression of Map3k2 than did any other colonic cell population analyzed (Figures 4B and 4C ). Importantly, we further observed that Rspo1 expression in CD90 + IMSC was significantly up-regulated following DSS treatment (Figure 4D ), but only in the presence of functional Map3k2 (Figure 4D) . These data demonstrate that CD90 + IMSC are likely the key stromal population responsible for Map3k2-mediated gut tissue repair.
In order to confirm that CD90 + IMSC are physiologically important for supporting the growth of intestinal epithelial stem cells, we performed a stroma-organoid co-culture experiment using isolated CD90 + IMSC or CD90 -IMSC co-cultured together with colonic crypts in the absence of exogenous R-spondin1. Organoids displayed only limited growth when cultured in isolation, whereas co-culture with CD90 + IMSC led to a marked increase in overall size and the percentages of spheroids (Figures S2D and S2E) . Intriguingly, CD90 -IMSC not only failed to promote growth but actually appeared to inhibit organoid expansion when compared with cultures that lacked any stroma (Figures S2D and S2E) . Having already established that Map3k2-deficient CD90 + IMSC was poor inducers of R-spondin1, which was essential for growth and survival of intestinal organoids (Figure S2A) , we next assessed whether CD90 + IMSC were still able to support organoid growth after deletion of the Map3k2 gene. Using the same stroma-organoid co-culture approach, we observed that CD90 + IMSC from WT mouse colon were potent inducers of colonic organoid growth after DSS exposure, forming more spheroids with greater circumference than could be established by their Map3k2-deficient counterparts ( Figures 4E-4G ). In contrast, in animals that did not receive DSS, colonic CD90 + IMSC derived from either WT or Map3k2 -/mice displayed similar capacities to support organoid growth (Figures 4E-4G ). All together, these results strongly suggest that the protective function of Map3k2 in the gut is mediated by CD90 + but not CD90 -IMSC.
Map3k2-Regulated CD90 + IMSC Are Localized to the Colonic Sub-Crypt
To determine the anatomical location of Map3k2-regulated CD90 + IMSC in the gut, we next performed immunofluorescent staining using stromal specific markers together with an anti-CD90 antibody. As shown in Figure S3A , we observed characteristic CD90 staining of the lamina propria T cells or innate lymphoid cells (ILCs), but also detected a specific population of CD90 + gp38 + cells located just below the crypts where LGR5-EGFP+ stem cells were also situated as described in a recent study ( Figure S3A ) (Karpus et al., 2019) . However, despite lacking the epithelial marker CD326 and leukocyte antigen CD45, further analysis of this population revealed a monolayer-like structure that is not typical of mesenchymal stroma, and subsequent whole-mount anti-CD90 staining identified this as a nexus of lymphatic vessels that co-stained for the endothelial marker LYVE1 (Figures S3B and S3C , Video 1 and Video 2). We therefore reverted to flow cytometry in order to perform a systemic analysis of which colonic subsets express CD90. IEC and gp38stromal cells were found to express little CD90, and only a very small fraction of CD45 + cells expressed this molecule (likely the T-cells and ILCs; Figures S3D and S3E) . Between 30-50% of blood endothelial cells (BEC) and gp38 + IMSC were found to express moderate levels of CD90, whereas high-level expression of this marker was restricted to lymphatic endothelial cells (LEC) ( Figure   S3E ). Indeed, when assessed by flow cytometry, LEC expression levels of CD90 were approximately 10-fold higher than those detected for Map3k2-regulated gp38 + IMSC (Figure S3E ).
While we anticipate that CD90 + IMSC are situated in a similar location to LEC in vivo, the levels of CD90 expressed by lymphatic endothelial cells prevented Map3k2-dependent CD90 + IMSC from being confidently located by microscopy. Consequently, we hereafter refer to CD90 + IMSC as 'CD90 medium-high' (CD90 mid ) cells.
Although CD90 staining did not reveal the identity of the Map3k2-regulated IMSC, a subcrypt location for these cells could be predicted due to the profound effect of Map3k2 deletion on the ISC niche after DSS challenge. To examine this possibility, we used the fluorescence in situ hybridization (FISH)-based technique RNAScope to detect Rspo1 mRNA in tissue sections, which revealed that DSS exposure in drinking water was able to induce Rspo1 expression in the colonic epithelium of WT mice (Figure 4H ). Quantitation of Rspo1 expression levels showed marked induction in the base areas of the sub-epithelium after DSS-treatment, but this was blunted in colon from Map3k2 -/mice ( Figure 4I) . In contrast, Rspo1 expression in the middle and top layers of the sub-epithelial region was comparable in colons from both WT and Map3k2-deficient animals, irrespective of DSS treatment (Figure 4I ). Together, these data suggest that Map3k2-mediated Rspo1 expression defines a novel ISC niche located at the bottom of the crypts.
Single-cell RNA-Seq Reveals that CD90 mid CD34 + CD81 + IMSC Require Map3k2 for DSSinduced Rspo1 Expression
Having determined that CD90 mid IMSC are likely the critical subset of Map3k2-regulated cells expressing Rspo1 in response to acute gut injury, we next sought to uncover the precise features of this stromal population using droplet-based scRNA-seq. First, we sorted CD90 mid IMSC from DSS-treated colonic lamina propria by gating out hematopoietic cells (CD45 + ), epithelial cells (CD326 + ), endothelial cells (CD31 + ), and gp38stromal cells (gp38 -) ( Figure S4A and S4B Figure 5A ). Among these populations, clusters 2, 5, and 8 were found to express Rspo1 at high levels, identifying these as candidate Map3k2-regulated stromal cells potentially capable of responding to DSS-induced gut tissue damage (Figure 5C ). Of these subsets, cluster 8 mesothelial cells are situated away from the crypt region and are thus unlikely to play a direct role in supporting epithelial reconstitution. We therefore focused subsequent analyses on the remaining Rspo1-expressing cell clusters 2 and 5.
To investigate the properties of these two stromal cell populations, we first examined the characteristic marker genes that differentiated these into clusters 2 and 5. Differentially expressed gene analysis indicated that cluster 2 was more pro-inflammatory, as indicated by preferential expression of leukocyte/endothelial cell chemokine Cxcl14 and the activation-linked transcription factor Mafb. In contrast, cluster 5 cells displayed a profile consistent with involvement in tissue remodeling, and preferentially expressed the neuro-regulator Penk, Wnt modulator Sfrp4, and cell development regulator tetraspanin Cd81 (Figure 5D ). Since both cluster 2 and 5 cell subsets lacked genes such as Sox6 that were characteristic of other niche-associated stromal cells such as telocytes (Shoshkes-Carmel et al., 2018) , these data suggest that the populations detected by our analyses represent two previously unknown stromal cell lineages with potential roles in regulating the intestinal stem cell niche (Figure 5D ).
Using violin plots to compare specific gene expression within the different cell populations, we found that cluster 2 population expressed mediators typically associated with angiogenesis (Cxcl14 and Agt), whereas cluster 5 cells were found to express genes potentially related to tissue damage and repair (Figf and Ccl7) ( Figure 5E ). Indeed, cluster 2 cells were further defined by unique expression of the transcription factors Snai1 and Id1, while cluster 5 cells instead expressed Ar and Ebf1 (Figure 5E ), indicating that these two stromal lineages exert different functions in the colon. In order to facilitate further analysis of these populations by flow cytometry, we next examined their expression profiles of cell-surface markers, which revealed that cluster 5 cells displayed high level of CD81 and CD34 but not CD138 (Sdc1), whereas cluster 2 cells lacked CD81 and CD34 but were CD138 positive ( Figure 5F) . To determine which of these populations was the major Map3k2-regulated subset involved in gut tissue repair, we next stained colonic lamina propria single cell suspensions with a panel of lineage-defining antibodies (CD326, CD45, CD31, gp38, CD90, CD81, CD34, CD138). The results revealed that about 82.4% of CD81 + CD90 mid stromal cells, which were fewer than ~4% of the total gp38 + stromal cells, were likely cluster 5 cells, whereas 10.2% of CD81 -CD90 mid stromal cells belonged to cluster 2 ( Figure   5G ). When we sorted these two populations of Rspo1 + IMSC from unchallenged mice, we observed comparably-sized populations in both WT and Map3k2-deficient colon (Figures 5H and 5I) . After DSS treatment, we detected a very small increase of cluster 5 cell frequency (CD90 mid CD34 + CD81 + CD138 -) in both WT and Map3k2 -/mice (Figure 5H) , whereas cluster 2 cells (CD90 mid CD81 -CD34 -CD138 + ) appeared unaffected by DSS damage (Figure 5I ). Furthermore, basal expression of Rspo1 gene was similar in cluster 5 cells from both WT and Map3k2 -/mice, but after DSS administration expression of Rspo1 in this cluster was substantially upregulated only in Map3k2-competent cells (Figure 5J) . In contrast, cluster 2 cells expressed comparable low levels of Rspo1 in both WT and Map3k2 animals, and the modest increase in Rspo1 observed after DSS challenge appeared unaffected by the absence of functional Map3k2 (Figure 5J ). Together, these data demonstrate that the use of common lineage markers together with CD81 and CD34 has identified cluster 2 as the Map3k2-regulated stromal cells implicated in ISC niche maintenance.
If Map3k2-dependent CD81 + CD34 + stromal cells were a genuine niche-forming population, we would expect these cells to be situated in close proximity to intestinal stem cells. Before testing this hypothesis using imaging approaches, we first validated our staining strategy by using flow cytometry to determine which colonic lamina propria populations express both CD81 and CD34. As shown in Figure 5K , IECs displayed only low-level expression of CD81 while completely lacking CD34, and the few CD45 + leukocytes that stained positive for CD81 were mostly negative for CD34. LECs were consistently negative for both markers. Around 38.8% of BECs expressed modest levels of CD34 in conjunction with CD81, but these cells could be clearly distinguished from stromal cells based on the additional expression of CD31. Finally, dual expression of CD81 and CD34 was negligible among gp38stromal cells and totally absent within the CD90stromal compartment. Taken together, these data confirmed that ~12% of the CD90 mid stromal population could be uniquely defined as CD81 + CD34 + 'double-positive' cells, and could therefore be identified by image analysis for assessment of their tissue distribution within the gut.
We next used antibodies against CD81, CD34 and CD31 to perform immunofluorescence analysis of colon sections in order to determine whether CD81 + CD34 + stromal cells could be identified within the sub-crypt region. While anti-CD81 antibody labelled most cells in colon (red), no staining was observed within the sub-crypt region which was instead dominated by CD34 (green) co-expression with CD31 (blue) indicative of endothelial cells (BEC, LECs) ( Figure 5L ). However, we were also able to detect CD31cells that co-expressed CD81 and CD34 (yellow) near the bottom of the crypts, where they appeared to be tightly associated with lymphatic vessels (Figure 5L, Video 3). These results may explain why we were previously unable to visualize these cells using only anti-CD90 staining, since this marker is expressed at 10-fold higher levels by adjacent LECs (Figure S3E) . Taken together, these data indicate that a novel lineage of colonic mesenchymal stromal cells defined by co-expression of CD81 and CD34 (but not CD31) is situated close to the lymphatic vessels and depends on Map3k2 to induce Rspo1 expression following DSS-induced tissue damage. Hereafter, these cells will be referred to as Map3k2-regulated intestinal stromal cells (MRISC).
Conditional Ablation of Map3k2 in Mice Confirms its Intestinal Stromal Cell Specific Roles
To conclusively demonstrate the stromal cell specific role of Map3k2 in vivo for its protection of damaged colon, we next generated a Map3k2 floxed (Map3k2 fl/fl ) mouse line by inserting two loxp sequences flanking the exon 5 of Map3k2 gene (Figure S5A) . The tissue specific deletion of Map3k2 gene in these mice was confirmed by first crossing these mice with a T cell However, we found out that this particular transgenic Cre line could not delete the target genes from the gut stromal cells effectively although it was reported to delete genes in stromal cells in other organs/tissues (Data not shown). Therefore, we generated a new stromal specific Col1a2-Cre ERT2 line, in which a Cre ERT2 -WPRE-polyA cassette was inserted in the first exon of Col1a2 gene in frame with the translational starting codon between the 5'UTR and the coding sequence (CDS) (Figure S5D and S5E) . To confirm that the Col1a2-Cre ERT2 line could lead to specific Map3k2 gene deletion in the colon stromal cells, we sorted the CD326 + IEC, CD45 + leukocytes, CD31 + endothelial cells (CD45 -CD326 -CD31 + ), and gp38 + intestinal mesenchymal stromal cells (IMSC) (CD45 -CD31 -CD326 -gp38 + ) from the tamoxifen treated Map3k2 fl/fl and Col1a2-Cre ERT :Map3k2 fl/fl mouse colon, and performed qRT-PCR for the expression of Map3k2. As shown in Figure 6A , we found that Map3k2 expression was efficiently and specifically ablated only in IMSC from the tamoxifen treated Col1a2-Cre ERT2 :Map3k2 fl/fl mouse colon but not from the control tamoxifen treated Map3k2 fl/fl mouse colon. Furthermore, Map3k2 expression was not affected in CD326 + IEC, CD45 + leukocytes, or CD31 + endothelial cells sorted from either the tamoxifen treated control Map3k2 fl/fl or Col1a2-Cre ERT2 :Map3k2 fl/fl mouse colon (Figure 6A) . This is consistent with our scRNA-seq data that Col1a2 is specifically expressed in colon stromal cells (data not shown).
Together these data demonstrate that tamoxifen treatment of Col1a2-Cre ERT2 :Map3k2 fl/fl mice could achieve stromal specific deletion of Map3k2 in mouse colon.
We next performed DSS-induced colitis experiments with co-housed littermates of Similar to their roles in other organs and tissues, mesenchymal cells in the intestine are key regulators of epithelial homeostasis, matrix remodeling, immunity, and inflammation (Owens and Simmons, 2013; Pinchuk et al., 2010; Powell et al., 2011) . While mesenchymal stromal cells in the gut express a range of common marker genes including Pdpn, Vim, Col1a, Col1b, Col6a, increasing evidence suggests that there is extensive heterogeneity within this compartment (Kinchen et al., 2018) . However, at present there are no known phenotypic markers that allow unique stromal cell subsets to be distinguished within this heterogeneous group. In the current study, our analyses of Map3k2 function in experimental colitis revealed that a specific subset of stromal cells critically depends on this enzyme to mediate damage-induced Rspo1 expression. Further investigation confirmed that this novel population displayed moderate expression of CD90, which subsequently analysis of this subset by multi-parameter flow cytometry (although lymphatic endothelial cells [LEC] located within the same sub-crypt region express 10-fold higher levels of CD90 that can complicate immunostaining approaches). Specific surface markers that define MRISC were identified using scRNA-seq, which revealed that these stromal cells also express CD81 and CD34 but lack CD31 and CD138. When used in combination, these markers facilitated MRISC visualization without the need for CD90 staining, which allowed subsequent confirmation that MRISC cells are located near to Lgr5 + intestinal stem cells within the sub-crypt region. Indeed, MRISC also appeared to interact with adjacent LECs and local immune cells, suggesting that this lineage may indeed organize multiple cell types into a specific stem cell niche in the gut.
Intriguingly, while our data demonstrate that MRISC are critically important for regeneration and repair of the damaged intestine, these cells, or at least the Map3k2-Rspo1 axis in these cells, may not be essential for normal gut maintenance or homeostasis. These findings contrast with the recent identification of telocytes and Gli1-expressing stromal cells that appear critical for steady-state maintenance of the intestine (Degirmenci et al., 2018; Shoshkes-Carmel et al., 2018) .
Indeed, while telocytes are Foxl1 + stromal cells that populate the sub-epithelium from stomach to colon, we observed that MRISC are Foxl1cells with distinct morphology and localization characteristics. Similarly, while Gli1-expressing stromal cells (including Foxl1 + telocytes) are essential sources of Wnt in the intestine, it is unknown whether these cells are involved in driving colonic Rspo1 expression and stem cell proliferation in the damaged gut as was demonstrated for MRISC. Based on these differences in gene expression, cell morphology, distribution, and unique responsiveness to tissue damage, we propose that MRISC are a novel population of intestinal stromal cells with important niche functions distinct from either telocytes or Gli1-expressing stromal subsets.
Wnt and BMP ligands form a gradient of antagonistic signals in the gut that are known to regulate epithelial renewal and crypt-villi maintenance (Angerer et al., 2016) . While the CD81 + CD90 mid MRISC identified in our study might be predicted to produce Rspo1 and maintain a steady level of Wnt signaling in the intestinal stem cell niche, little is known about how Wnt signals are regulated following acute intestinal damage. In addition to Rspo1, MRISC were also observed to express Rspo3 and Wnt ligands Wnt2b, Wnt5a and the BMP pathway inhibitors Gremlin1, Gremlin2, further indicating that MRISC may also have a potential role in supporting ISC niche.
Gut microbiome has been shown to be critical for intestinal homeostasis and tissue regeneration (Elinav et al., 2011) . It is possible that the Map3k2 mediated protection of gut damage might be affected by commensal bacteria or Map3k2 deficient mice may have a disorder in gut microbiome leading to more severe colitis. However, all our mice were co-housed and treated with DSS together. In addition, we also delivered antibiotics cocktail (Ampicillin, Vancomycin, Neomycin, Metronidazole, and Gentamycin) to either WT or Map3k2 deficient mice before and during colitis induction with DSS, and observed similar results in co-housed mice as those nontreated mice (Data Not Shown). Therefore, the host microbiome is unlikely the major factor for the Map3k2 deficiency caused severe gut damage.
In summary, our study reveals that a novel population of Map3k2-regulated intestinal stromal cells (MRISC) is crucial for induction of Rspo1 and Wnt signaling which promote rapid 1 stem cell proliferation in response to acute intestinal damage. The sub-crypt location of MRISC likely reflects a requirement for direct communication with ISC following tissue injury, although it is currently unclear whether MRISC expression of additional mediators such as IL-6 and IL-33 reflects an ability to interact with other nearby cell types e.g. ILCs, macrophages, and neutrophils.
Deeper investigation of the roles played by MRISC in restraining intestinal inflammation and immunopathology will shed important new light on a range of major pathological conditions. In particular, these studies may provide new rationales for use of MAPK inhibitors or Wnt modulators for the treatment of IBD and colitis-associated colorectal cancer. (F) WT and Map3k2 -/co-housing littermate mice were administered 2% DSS in drinking water and then sacrificed on day 0, 3, 5, or 7 (n=3-4 mice/time-point). A separate group of mice was subjected to the same regimen for 7 days then transferred to regular drinking water for 2 days prior to sacrifice (Day 9) (n=3). Shown are representative AB/PAS staining of WT and Map3k2 -/mouse colons.
Figure legends
(G) Goblet cell number per crypt in mice treated as described in panel (F) (20 crypts were counted in total from n=3 animals per time point).
(H) mRNA expression levels of goblet cell marker gene Muc2 in colon tissue from mice treated as described in panel (F). Data shown are normalized to Hprt expression level.
Error bars indicate mean ± SEM (*p<0.05, **p<0.01, ***p< 0.001 by unpaired Student's t test). (E) Map3k2 -/mice (n=5/group) were administered 2% DSS in drinking water for 7 days followed by regular drinking water for 2 days. Human recombinant R-spondin1 was injected at a daily dose of 5µg/mouse (from day 1-9). Control mice received saline injection only. Body weight was monitored daily.
Figure 2. Map3k2 Maintains Intestinal Stem Cell Frequency Following Tissue Damage
(F) Daily stool scores from mice treated as described in panel (E).
(G) Il6 and Tnfa mRNA expression levels in colon tissue from mice treated as described in panel (E) before sacrifice on day 9. Data shown are normalized to Hprt expression level.
(H) Representative Alcian Blue/Periodic Acid Schiff (AB/PAS) staining of colons from mice treated as described in panel (E) before sacrifice on day 9 (left panels). Goblet cell number per crypt is shown on the right (n=5 mice/group, 30 crypts counted per group).
(I) Lgr5 mRNA expression in colon tissue from mice treated as described in panel (E) before sacrifice on day 9. Data shown are normalized to Hprt expression level.
Error bars indicate mean ± SEM (*p<0.05, **p<0.01, ***p<0.001 by unpaired Student's t test). (G) Representative flow cytometry plots showing percentage of cluster 5 stromal cells (CD45 -, CD31 -, CD326 -, gp38 + , C90 mid , CD81 + , CD34 + , CD138 -) and cluster 2 stromal cells (CD45 -, CD31 -, CD326 -, gp38 + , CD90 mid , CD81 -, CD34 -, CD138 + ) in WT colonic lamina propria.
(H) Bar graph quantitation of the percentage of cluster 5 stromal cells (CD45 -, CD31 -, CD326 -, gp38 + , CD90 mid , CD81 + , CD34 + , CD138 -) in gp38 + stromal cells as assessed by flow cytometry analysis in WT and Map3k2 -/mouse colons (each n=3) after treatment or not with DSS as indicated.
Shown are representative plots from three independent experiments.
(I) Bar graph quantitation of the percentage of cluster 2 stromal cells (CD45 -, CD31 -, CD326 -, gp38 + , CD90 mid , CD81 + , CD34 + , CD138 -) in gp38 + stromal cells as determined by flow cytometry analysis in WT and Map3k2 -/mouse colons (each n=3) after 2 days exposure to DSS (or water only control) as indicated.
(J) Intestinal stromal cell clusters 2 and 5 were FACS-sorted from the colonic tissue of WT and Map3k2 -/mice (each n=3) after 2 days exposure to DSS (or water only control) and total RNA was extracted for detection of Rspo1 mRNA. Data are normalized to Hprt expression level.
(K) Flow cytometry analysis of CD34 and CD81 expression in WT colonic lamina propria showing IEC (CD326 + ), CD45 + leukocytes, LECs (CD45 -CD326 -CD31 + gp38 + ), BECs (CD45 -CD326 -CD31 + gp38 -), gp38cells (CD45 -CD326 -CD31 -gp38 -), CD90stromal cells (CD45 -CD326 -CD31 -gp38 + CD90 -) and CD90 mid stromal cells (CD45 -CD326 -CD31 -gp38 + CD90 mid ). Plots are representative of three independent experiments.
(L) WT mouse colon was harvested and processed into swiss roll sections for staining with anti-CD81 (red), anti-CD34 (green), anti-CD31 (blue) and then visualized using a Leica SP8 microscope with 63x oil objective lens. The top row panels show the images of three separate channels as were injected intraperitoneally with tamoxifen (TM) every two days (2 mg/mouse/time, 5 times).
After 3 weeks from the last time of injection, mice were administered with 2% DSS in drinking water for 7 days followed by regular drinking water for additional 2 days. Body weights were recorded daily. with 2% DSS in drinking water for 7 days followed by regular drinking water for additional 2 days.
Body weights were recorded daily. Shown is a representative graph of two independent experiments.
(I) Daily stool scores for mice treated as described in panel (H).
(J) Bar graphs show colon length of mice treated as described in panel (H) before sacrifice on day 9.
(K) Hematoxylin and eosin (H&E) staining of colon (left panels) and histological assessment of the mucosa (right panels) in mice treated as described in panel (H) before sacrifice on day 9.
(L) Colonic mRNA expression levels of Lgr5 and Il6 in mice treated as described in panel (H) before sacrifice on day 9. Data shown are normalized to Hprt expression level.
Error bars indicate mean ± SEM (*p<0.05, **p<0.01 ***p< 0.001 by unpaired Student's t test). A  m  i  r  e  l  ,  A  .  D  .  ,  D  a  v  i  s  ,  K  .  L  .  ,  T  a  d  m  o  r  ,  M  .  D  .  ,  S  i  m  o  n  d  s  ,  E  .  F  .  ,  L  e  v  i  n  e  ,  J  .  H  .  ,  B  e  n  d  a  l  l  ,  S  .  C  .  ,  S  h  e  n  f  e  l  d  ,  D  .  K  .  ,  K  r  i  s  h  n  a  s  w  a  m  y  ,  S  .  ,  N  o  l  a  n  ,  G  .  P  .  ,  a  n  d  P  e  '  e  r  ,  D  .  (  2  0  1  3  )  .  v  i  S  N  E  e  n  a  b  l  e  s  v  i  s  u  a  l  i  z  a  t  i  o  n  o  f  h  i  g  h  d  i  m  e  n  s  i  o  n  a  l  s  i  n  g  l  e  -c  e  l  l  d  a  t  a  a  n  d  r  e  v  e  a  l  s  p  h  e  n  o  t  y  p  i  c 
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